Carter, R. F. (2017) “Do you believe that N-of-1 trials (a clinical trial in which a single patient is the entire trial), are appropriate to evaluate the effectiveness of genomic therapies for rare and/or common genetic disorders? Do gene-editing/targeting therapies have the potential to expedite the advancement of personalized medicine?”, Health Science Inquiry, 8(1), p. Page 60-Page 61. doi: 10.29173/hsi223.